TransformBio
A new approach to drug development.
Combining novel drug design and re-purposing with decentralized ecosystem for digital transformation.
TransformBio continues to monitor the situation surrounding the COVID-19
pandemic and its potential impact on our team, our partners and our business.
Orchestrated Innovation in Drug Development
Early Patient Engagement,
re-purposing, unmet needs
Formulation, delivery
mechanism
Patient reported outcomes,
digital tools for HCPs
Novel Drug design and
drug delivery
Virtual & decentralized
clinical trials
Engage with pharmacies and emerging retailers